RRRamya Rajendran

Ramya Rajendran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ramya Rajendran has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • G. Balakrishnan

    Central University Laboratory, Centre for Animal Health Studies, Tamil Nadu Veterinary and Animal Sciences University, Madhavaram Milk Colony, Chennai 600051, India

    2 shared publications
  • Kumaragurubaran Karthik

    Veterinary College and Research Institute, Udumalpet, Tamil Nadu Veterinary and Animal Sciences University, Chennai, India

    2 shared publications
  • Madhanmohan Muthukrishnan

    Vaccine Research Centre-Viral Vaccines, Centre for Animal Health Studies, Tamil Nadu Veterinary and Animal Sciences University, Madhavaram Milk Colony, Chennai 600051, India

    2 shared publications
  • Madhuri Subbiah

    National Institute of Animal Biotechnology, Hyderabad, India

    2 shared publications
  • Revathi Shunmuga Sundaram

    National Institute of Animal Biotechnology, Hyderabad, Telangana 500032, India

    2 shared publications
  • A. Raman

    Center for Animal Health Studies Central University Laboratory Tamil Nadu Veterinary and Animal Sciences University - 600 051 Chennai Tamil Nadu India

    1 shared publication

Latest Publications

  • Molecular and phylogenetic analyses of the first complete genome sequence of Duck hepatitis A virus genotype 2 from India

    by Ramya Rajendran, Revathi Shunmuga Sundaram, Pachineella Lakshmana Rao, D.JAya Senthil Nathan, Madhanmohan Muthukrishnan, Seeralan Manoharan, Jaisree Srinivasan, G. Balakrishnan, C Soundararajan, Madhuri Subbiah


  • Open Access

    Molecular Confirmation of Moraxella Bovis Associated Infectious Keratoconjunctivitis in Ruminants

    by G. Kalaiselvi, G. Balakrishnan, A. Raman, N. Jayanthi, R. Ramya, C. Soundararajan

    Background: Infectious keratoconjunctivitis is a significant problem causing a greater level of economic losses in production animals. The affected animals show progressive cloudiness of eye, severe congestion of ocular mucous membrane with inflammation of cornea, ocular discharges vary from serous to purulent and causes temporary or permanent blindness in affected animals. Methods: A total number of 238 conjunctival swabs were collected from the suspected cases (93 sheep, 98 goats and 47 cattle) of different age groups in both symptomatic and asymptomatic animals during the period of 2021-2023 (both winter and summer season in livestock farms of Tamil Nadu, SBRS –Ooty, PGRIS-Katuakkam, Tirvananamalai, Sheep Research Station-Potaneri, Tiruvallur district). The samples were subjected to bacterial isolation and identification. The bacterial organism isolated from the swabs were characterized by cultural, biochemical and molecular tests. Result: The Moraxella species was successfully isolated from 9 animals (N=5 in cattle and N=4 in sheep). In addition to this Staphylococcus and Klebsiella, (N=34), Streptococcus (N=10), Pseudomonas (N=8) and concurrent infection of Tricophyton verrocosum, Aspergillus. The genomic DNA was extracted from positive culture of morexalla and PCR amplification was performed with specific primers. The amplified PCR product were subjected to partial gene sequencing which showed 99% homology with other, Morexalla bovis isolates. Antimicrobial sensitivity test of the isolates revealed that Moraxella was sensitive towards Chloramphenicol (100%), Ciprofloxacin (100%), Gentamicin (100%), Tylosin (100%) and sensitive to Oxytetracycline (80%), Endrofloxacin (80%), Gatifloxacin (80%) and Metronidazole (70%). All tested isolates were resistant to Norfloxacin, Vancomycin, Ampicillin /Sulbactam, Methicillin and Sulphadiazine.


  • Foremost report of the whole genome of Spirabiliibacterium mucosae from India and comparative genomics of the novel genus Spirabiliibacterium

    by Kumaragurubaran Karthik, Subbaiyan Anbazhagan, Murugesan Ananda Chitra, Rajendran Ramya, Ramaswamy Sridhar, Gopal Dhinakar Raj


  • First report of Duck Hepatitis A virus genotype 2 in India

    by Ramya Rajendran, Jaisree Srinivasan, Jayanthi Natarajan, Kalaiselvi Govindan, Karthik Kumaragurubaran, Madhanmohan Muthukrishnan, Manoharan Seeralan, Madhuri Subbiah, Revathi Shunmuga Sundaram, Pachineella Lakshmana Rao, et al.

    Sudden death of ducklings was reported in a duck farm located at Tiruvallur district in Tamil Nadu, India. Disease investigation began with post mortem findings of dead birds revealing enlarged pale-pink / pale-yellow liver with multifocal petechiae and ecchymosis. A positive amplification with duck hepatitis A virus specific primers by reverse transcription-polymerase chain reaction (RT-PCR) on the tissue samples collected from dead birds indicated infection by duck hepatitis A virus (DHAV), an avian picornavirus, known to cause acute and high-mortality in ducklings. The virus isolation was successful in 9-days old embryonated chicken eggs, in primary chicken embryo fibroblast (CEF) cells and from experimentally infected ducklings. The embryonic death on day 5 to 7 post inoculation in chicken embryos with signs of cutaneous hemorrhage, edema and greenish yellow liver together with histopathology of embryonic liver and kidney further confirmed DHAV infection. TEM analysis of the infected allantoic fluid and infected CEF cell culture supernatant showed the presence of spherical shaped, non-enveloped virion particles of ~ 20–38 nm diameter, typical for DHAV. Experimental infection of ducklings with RT-PCR positive tissue supernatant caused 40% to 50% mortality with typical petechial hemorrhages on the surface of liver. Further, histopathological analysis and RT-PCR of the inoculated duckling’s tissues confirmed the presence of DHAV. Nucleotide sequencing of the 5′UTR region and VP1 region confirmed duck hepatitis A virus genotype 2 (DHAV-2). To the best of our knowledge, this is the first report of laboratory confirmation of DHAV-2 in India. This study warrants the need for the extensive epidemiological surveillance to understand the prevalence of DHAV-2 in India and to take appropriate control measures to curtail the disease spread.